An interventional study of Standard Synthetic Transobturator Tape (TOT) and Hybrid Transobturator Tape Sling in Stress Urinary Incontinence (SUI), Transobturator Tape and Hybrid Sling, sponsored by Benha University. Recruiting at 1 site in Egypt. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-13.
Sponsored by Benha University · Not applicable, Interventional, and Treatment
Among 39 studies in Urinary Incontinence, Stress with a site in Egypt — 15 open to participants now, 19 under way, none of them phase 3. Urinary Incontinence, Stress · Egypt.
Among the 39 studies in Urinary Incontinence, Stress with a site in Egypt, this one is the 9th largest by planned enrollment of the 31 interventional ones that give a count, is one of 6 that started in 2026, is one of 23 with no phase, reaches primary completion later than 16 of the 18 other live ones, and was the 37th registered.
653 studies on the registry are indexed under Urinary Incontinence, Stress; 121 are open to participants now.
Browse Urinary Incontinence, Stress studies →15 of the 39 studies in Urinary Incontinence, Stress with a site in Egypt are open now. Recruiting first, the newest first:
Benha University · Sites in Egypt
Ages 50–65 · Women only · Healthy volunteers
Al-Azhar University · Sites in Egypt
Ages 20–45 · Women only
Cairo University · Sites in Egypt
Ages 40–60 · Women only
Cairo University · Sites in Egypt
Ages 18–65 · Women only
Ain Shams University · Sites in Egypt
Ages 18–45 · Women only
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 74 Urinary Incontinence, Stress studies recruiting now, 42 (57%) set no upper age limit and 18 (24%) stop at 75 or younger; 2 take children under 18; 16 take healthy volunteers.
This study: 18 Years and older · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
39 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 5 · Phase 3 6
First in 2014; this study’s year is marked. 6 started in 2026.
This study's planned enrollment of 90 is above the median of 68 across 508 interventional studies indexed under Urinary Incontinence, Stress.
Median enrollment 60 across the 31 interventional studies, 122 across the 8 observational. Of the 14 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 39 have an industry lead sponsor. The 10 most frequent:
Benha University is the lead sponsor of 362 studies on the registry; 66 are open to participants now.
Benha University has 4 studies filed under Urinary Incontinence, Stress — fewer than ten, so there is no comparison to draw.
4 of the studies in Urinary Incontinence, Stress with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07661264Cairo UniversityEffect of Different Pelvic Floor Loading Techniques on Women With Stress Urinary Incontinence | 2026-12-15 |
| NCT07762300Benha UniversityHybrid Transobturator Tape Versus Conventional Synthetic Tape for Stress Urinary Incontinence | 2027-03-01 |
| NCT07807982Benha UniversityPeri-Urethral Platelet-Rich Plasma Injections for Postmenopausal Female Stress Urinary Incontinence | 2027-03-15 |
| NCT07550426Ain Shams UniversityThe Effect of Periurethral Injection of Platelet Rich Plasma Versus Mid-urethral Sling in Treatment of Stress Urinary Incontinence | 2027-04-15 |
Add all 4 to your calendar (.ics) → With an account.
Among the 39 studies in Urinary Incontinence, Stress with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized controlled trial compares the safety, efficacy, and impact on female sexual function of a novel hybrid transobturator tape (combining an autologous rectus fascia strip with a polypropylene mesh) versus standard synthetic transobturator tape in women undergoing surgery for stress urinary incontinence.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients undergo the standard outside-in transobturator tape procedure using a full synthetic polypropylene tape.
Procedure: Standard Synthetic Transobturator Tape (TOT)
Patients undergo the hybrid sling procedure using a composite graft consisting of an autologous rectus fascia strip centrally sutured to polypropylene tape arms.
Procedure: Hybrid Transobturator Tape Sling
Outside-in transobturator tape procedure utilizing a full synthetic polypropylene tape positioned tension-free under the mid-urethra.
Insertion of a composite graft (autologous rectus fascia strip harvested via a Pfannenstiel incision and sutured between polypropylene tape arms) positioned via the obturator foramen route with the biological tissue directly under the mid-urethra.
Incidence of mesh-related complications (including vaginal erosion, extrusion, and chronic groin pain).
Evaluation of local tissue complications and adverse events associated with the sling material.
Time frame: Assessed at 6 months postoperatively.
Objective cure rate
Clinical confirmation of urinary continence via standardized cough stress testing and urodynamic assessments (uroflowmetry and cystometry).
Time frame: Assessed at 6 months postoperatively.
Subjective cure rate and patient satisfaction.
Measured using the Patient Global Impression of Improvement (PGI-I) scale. The PGI-I is a 7-point single-item questionnaire with scores ranging from 1 ("Very much better") to 7 ("Very much worse"). Lower scores indicate greater clinical improvement and higher patient satisfaction.
Time frame: Assessed at 6 months postoperatively.
Impact on quality of life and female sexual function.
Evaluated using validated questionnaires including the International Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF). Total scores range from 0 to 21, where higher scores indicate greater severity of incontinence and worse impact on quality of life.
Time frame: Assessed at 6 months postoperatively
Female sexual function measured by the Female Sexual Function Index (FSFI)
Evaluated using the Female Sexual Function Index (FSFI), covering 6 domains (desire, arousal, lubrication, orgasm, satisfaction, and pain). Total full-scale scores range from 2.0 to 36.0, where higher scores indicate better sexual function.
Time frame: Assessed at 6 months postoperatively
Total Operative Time
Total time required to complete the surgical procedure, measured in minutes.
Time frame: Intraoperative (from initial skin incision to final wound closure).
Length of Postoperative Hospital Stay
Duration of hospital stay following surgery, measured in days.
Time frame: Postoperative Day 1 through hospital discharge (up to 7 days).
Plan to share: No — Individual participant data will not be shared externally in order to maintain participant confidentiality and privacy in accordance with local institutional ethics board guidelines.
Started Jul 2026 (actual). Primary completion is estimated for Mar 2027, 8 months after the start.
Of 226 non-industry interventional studies with no phase under Urinary Incontinence, Stress, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 8 months is below that.
Counting every sponsor, half of 267 studies reached it within 19 months; a quarter within 9 and three quarters within 43.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Urinary Incontinence, Stress →